Шукаєте відповіді та рішення тестів для BMS3031 - Molecular mechanisms of disease - S1 2026? Перегляньте нашу велику колекцію перевірених відповідей для BMS3031 - Molecular mechanisms of disease - S1 2026 в learning.monash.edu.
Отримайте миттєвий доступ до точних відповідей та детальних пояснень для питань вашого курсу. Наша платформа, створена спільнотою, допомагає студентам досягати успіху!
Genetic analyses suggest SARS‑CoV‑2 originated from bat coronaviruses with possible adaptation in intermediate mammalian hosts. Replication in these hosts allows viral evolution toward efficient interaction with mammalian ACE2‑like receptors, without eliminating the virus’s ability to circulate in reservoir species.
Over time, what consequence does this process most strongly promote?
Genomic surveillance shows that SARS‑CoV‑2 continues to accumulate mutations during global circulation. Many mutations affect the spike protein, particularly regions involved in immune recognition, while genes involved in core replication remain highly conserved. Variants with altered antigenic profiles repeatedly emerge and replace earlier strains.
Given prolonged global circulation in humans,
what long‑term pattern is most likely?
The Omicron variant of SARS‑CoV‑2 exhibited a much higher basic reproductive number (R₀) than earlier variants. Consider a future variant with a similarly high R₀ that causes very mild or subclinical infection in most individuals. Infected individuals frequently continue normal activities while infectious.
Across multiple epidemic waves, what population‑level consequence is most likely?
Following widespread vaccination and natural infection, much of the human population has partial immunity to SARS‑CoV‑2. A new variant arises that is less effectively neutralised by existing antibodies, while retaining strong ACE2 binding and efficient transmission. The variant shows no increased virulence or replication cost.
If introduced into such a population, what outcome is most likely over time?
SARS‑CoV‑2 has a lower case fatality rate than SARS or MERS, yet caused far greater global spread. Consider a hypothetical SARS‑CoV‑2 variant that increases disease severity modestly but causes earlier hospitalisation and reduces the duration of infectiousness in the community. Viral replication within the host remains unchanged.
Over successive transmission cycles, what impact would this most likely have on pandemic spread?
Coronaviruses frequently circulate in bat reservoirs, occasionally spilling over into humans where most infections fail to establish sustained transmission. A novel coronavirus spill-over event produces a virus capable of infecting human airway cells, but initially spreads inefficiently between people. Subsequent mutations improve human receptor binding and viral shedding without reducing replication in animal reservoirs or humans.
Given sufficient opportunity for adaptation and global population movement, what outcome best explains how such a virus could become pandemic?
Early analyses of COVID‑19 case numbers showed that viral spread strongly correlated with population movement from initial outbreak regions. Imagine a SARS‑CoV‑2–like virus emerges, but rapid international travel restrictions and large‑scale movement controls are implemented before widespread dissemination occurs. The virus retains the same biological transmissibility.
Given these conditions, what outcome is most likely over time?
Reassortment between avian and human influenza viruses generates a new subtype with a haemagglutinin to which humans lack immunity. The new virus transmits efficiently with no intrinsic fitness cost.
What is the most likely long‑term consequence following introduction into humans?
SARS‑CoV‑2 enters human cells by binding the ACE2 receptor via its spike protein. Genomic surveillance identifies a new viral variant carrying multiple spike mutations that significantly increase binding affinity to human ACE2. Laboratory studies show enhanced cell entry and higher transmission rates in animal and human airway models. Importantly, this variant shows no reduction in viral stability, replication efficiency, or disease severity compared to earlier strains.
Assuming sustained human‑to‑human transmission and no immediate population‑level immunity shift, what outcome is most likely over time?
CD8⁺ T cells recognise conserved internal influenza proteins such as NP and M1. Mutations in these regions often reduce viral replication efficiency. Variants retaining conserved sequences consistently show higher fitness.
Over long evolutionary timescales, what outcome is most likely?